Cite
HARVARD Citation
Blumenfeld Kan, S. et al. (2019). HDL-cholesterol elevation associated with fingolimod and dimethyl fumarate therapies in multiple sclerosis. Multiple sclerosis journal, experimental, translational and clinical. 5 (4), p. . [Online].